Study to evaluate the safety and efficacy of stem cell culture supernatant (stem cell secretome) nasal drip therapy. - Study to evaluate the safety and efficacy of stem cell culture supernatant (stem cell secretome) nasal drip therapy.

atural Harmony Clinic Omotesando0 个研究点目标入组 20 人开始时间: 2024年2月15日最近更新: 2024年5月27日

试验速览

暂无简介。

•[1]Patients suffering from dementia other than Alzheimer's disease (vascular dementia, Lewy body dementia, frontotemporal dementia, etc.). [2]Patients diagnosed with Alzheimer's disease who have a disease (medical disease, neurological disease, etc.) that causes dementia-like symptoms prior to Alzheimer's disease. [3]Patients with a significant neurological disease or severe mental disorder other than Alzheimer's disease. [4]Patients who are currently participating in other human clinical trials or who have not yet completed 3 months of participation in other human clinical trials. [5]Other patients who are judged by the principal investigator or cooperating investigator to be inappropriate as subjects for this study.

发起方

atural Harmony Clinic Omotesando